• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CONSERVE(R) TOTAL NECK SLEEVE; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CONSERVE(R) TOTAL NECK SLEEVE; HIP COMPONENT Back to Search Results
Model Number 38NS-3500
Device Problem Insufficient Information (3190)
Patient Problem Pain (1994)
Event Type  Injury  
Manufacturer Narrative
This complaint will be updated once investigation is complete.Trends will be evaluated.
 
Event Description
Allegedly the patient was revised due to pain (right).Adding patient name received 05/09/2018.Located invoice and updated item numbers.
 
Manufacturer Narrative
Update investigation codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSERVE(R) TOTAL NECK SLEEVE
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key7575739
MDR Text Key110320111
Report Number3010536692-2018-00770
Device Sequence Number1
Product Code KXA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 06/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model Number38NS-3500
Device Catalogue Number38NS-3500
Device Lot Number0711391120
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/09/2018
Initial Date Manufacturer Received 05/09/2018
Initial Date FDA Received06/06/2018
Supplement Dates Manufacturer Received05/09/2018
05/09/2018
Supplement Dates FDA Received12/17/2018
05/26/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-